PACS Group Inkomsten in het verleden
Verleden criteriumcontroles 1/6
PACS Group's earnings have been declining at an average annual rate of -30%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 28.8% per year. PACS Group's return on equity is 16%, and it has net margins of 2.6%.
Belangrijke informatie
-30.0%
Groei van de winst
-32.7%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 28.8% |
| Rendement op eigen vermogen | 16.0% |
| Nettomarge | 2.6% |
| Volgende winstupdate | 07 Nov 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe PACS Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 3,559 | 92 | 270 | 0 |
| 31 Mar 24 | 3,338 | 124 | 188 | 0 |
| 31 Dec 23 | 3,111 | 113 | 201 | 0 |
| 31 Dec 22 | 2,422 | 150 | 170 | 0 |
| 31 Dec 21 | 1,167 | 48 | 106 | 0 |
Kwaliteitswinsten: PACS has high quality earnings.
Groeiende winstmarge: PACS's current net profit margins (2.6%) are lower than last year (4.8%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: Insufficient data to determine if PACS's year-on-year earnings growth rate was positive over the past 5 years.
Versnelling van de groei: PACS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: PACS had negative earnings growth (-30%) over the past year, making it difficult to compare to the Healthcare industry average (11.4%).
Rendement op eigen vermogen
Hoge ROE: PACS's Return on Equity (16%) is considered low.